Skip to content

The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women

The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06951022
Enrollment
120
Registered
2025-04-30
Start date
2025-01-30
Completion date
2025-07-30
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopause, Urinary Incontinence (UI)

Keywords

Su Jok Therapy, Urinary Incontinence, Quality of Life, Postmenopausal Women

Brief summary

This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Participants in the intervention group will receive Su Jok seed therapy applied to the hand reflex points corresponding to the bladder. The therapy will be administered by the researcher and then taught to the participants, who will continue the application for 15 days. Assessments will be conducted at baseline, day 15, and day 30 using validated questionnaires.

Interventions

Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area.

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants in the experimental group will receive Su Jok seed therapy using apple seeds applied to the hand point that reflects the bladder. Participants will be trained to perform the therapy themselves and will apply it daily for 15 days. They will be reminded via daily messages and monitored for adherence.

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Women under 65 years of age in the postmenopausal period, Literate, No speech or communication impairment

Exclusion criteria

Use of diuretics Presence of nephrotic syndrome Diagnosis of diabetes or hypertension Symptoms of urinary tract infection Diagnosis of psychiatric illness History of urinary tract surgery Diagnosed urinary prolapse Failure to complete the intervention

Design outcomes

Primary

MeasureTime frameDescription
Change in quality of life measured by the Incontinence Quality of Life Scale (I-QOL)At baseline, 15 days and 30 days after interventionDescription: The I-QOL assesses quality of life, including behavioral limitation, psychosocial impact, and social isolation, in postmenopausal women with urinary incontinence. Scoring: Domain scores range from 0 to 100, where higher scores represent a poorer quality of life. Unit of Measure: Total score (0-100)
Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)At baseline, 15 days and 30 days after interventionDescription: The ICIQ-SF is a 4-item questionnaire used to evaluate the severity and impact of urinary incontinence. Scoring: Scores range from 0 to 21, with higher scores indicating more severe urinary incontinence. Unit of Measure: Points on a scale

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026